| Model-based analysis of postprandial glycemic response dynamics for different types of food YJ Rozendaal, AH Maas, C van Pul, EJ Cottaar, HR Haak, PA Hilbers, ... Clinical Nutrition Experimental 19, 32-45, 2018 | 43 | 2018 |
| A physiology-based model describing heterogeneity in glucose metabolism: the core of the Eindhoven Diabetes Education Simulator (E-DES) AH Maas, YJW Rozendaal, C van Pul, PAJ Hilbers, WJ Cottaar, HR Haak, ... Journal of diabetes science and technology 9 (2), 282-292, 2014 | 33 | 2014 |
| Genomic profiling of metastatic castration-resistant prostate cancer samples resistant to androgen receptor pathway inhibitors N Menssouri, L Poiraudeau, C Helissey, L Bigot, J Sabio, T Ibrahim, ... Clinical Cancer Research 29 (21), 4504-4517, 2023 | 25 | 2023 |
| In vivo and in silico dynamics of the development of Metabolic Syndrome YJW Rozendaal, Y Wang, Y Paalvast, LL Tambyrajah, Z Li, ... PLoS Computational Biology 14 (6), e1006145, 2018 | 25 | 2018 |
| Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes E Nyman, YJW Rozendaal, G Helmlinger, B Hamrén, MC Kjellsson, ... Interface focus 6 (2), 20150075, 2016 | 23 | 2016 |
| Characterization of immunoactive and immunotolerant CD4+ T cells in breast cancer by measuring activity of signaling pathways that determine immune cell function Y Wesseling-Rozendaal, A van Doorn, K Willard-Gallo, A van de Stolpe Cancers 14 (3), 490, 2022 | 18 | 2022 |
| Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways GF van Wigcheren, J Cuenca-Escalona, S Stelloo, J Brake, E Peeters, ... Journal of Biological Chemistry 299 (11), 105276, 2023 | 16 | 2023 |
| Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium P van der Ploeg, A Uittenboogaard, SL Bosch, PJ van Diest, ... Gynecologic Oncology 165 (1), 114-120, 2022 | 12 | 2022 |
| Computational modelling of energy balance in individuals with Metabolic Syndrome YJW Rozendaal, Y Wang, PAJ Hilbers, NAW van Riel BMC Systems Biology 13 (1), 24, 2019 | 12 | 2019 |
| Survival is related to estrogen signal transduction pathway activity in postmenopausal women diagnosed with high-grade serous ovarian carcinoma L van Lieshout, P van der Ploeg, Y Wesseling-Rozendaal, ... Cancers 13 (20), 5101, 2021 | 9 | 2021 |
| Measurement of activity of developmental signal transduction pathways to quantify stem cell pluripotency and phenotypically characterize differentiated cells L Holtzer, Y Wesseling-Rozendaal, W Verhaegh, A van de Stolpe Stem Cell Research 61, 102748, 2022 | 8* | 2022 |
| Spatiotemporal mapping of interictal epileptiform discharges in human absence epilepsy: a MEG study YJW Rozendaal, G van Luijtelaar, PPW Ossenblok Epilepsy research 119, 67-76, 2016 | 8 | 2016 |
| A systems analysis of phenotype heterogeneity in APOE* 3Leiden. CETP mice induced by Long-term high-fat high-cholesterol diet feeding Y Paalvast, E Zhou, YJW Rozendaal, Y Wang, A Gerding, TH van Dijk, ... Nutrients 14 (22), 4936, 2022 | 6 | 2022 |
| Exploring the relation between TGF-β pathway activity and response to checkpoint inhibition in patients with metastatic melanoma SG van Ravensteijn, AL Amir, DVF Tauriello, CML van Herpen, ... Clinical and Experimental Immunology 219 (1), uxae108, 2025 | 2 | 2025 |
| Abstract P5-02-08: Androgen receptor pathway activity and the ratio between androgen and estrogen receptor pathway activity in breast cancer subtypes A van de Stolpe, Y Wesseling-Rozendaal, MA de Inda, H van Ooijen, ... Cancer Research 80 (4_Supplement), P5-02-08-P5-02-08, 2020 | 2* | 2020 |
| Abstract A131: Fulvestrant resistance in an MCF-7 model for breast cancer is associated with complete loss of ER pathway activity and gain of MAPK-AP1 pathway activity Y Wesseling-Rozendaal, A Stolpe, L Holtzer, MA Inda, P Wiel Molecular Cancer Therapeutics 18 (12_Supplement), A131-A131, 2019 | 2 | 2019 |
| Identification of signal transduction pathway activity with potential clinical target in high-grade serous ovarian and tubal carcinoma. P van der Ploeg, LAM van Lieshout, YJW Wesseling-Rozendaal, ... Journal of Clinical Oncology 39 (15_suppl), e17541-e17541, 2021 | 1 | 2021 |
| Abstract C020: Quantitative measurements of functional activity of the TGFβ and MAPK-AP1 pathways in colon cancer provides information on their role in cancer development and … Y Wesseling-Rozendaal, P Swinderen, J Gil, S Neerken, A Stolpe Molecular Cancer Therapeutics 18 (12_Supplement), C020-C020, 2019 | 1 | 2019 |
| Increased PI3K pathway activity is associated with recurrent breast cancer in patients with low and intermediate 21-gene recurrence score LH Lin, Y Wesseling-Rozendaal, V Vasudevaraja, G Shen, M Black, ... Journal of clinical pathology 78 (10), 697-702, 2025 | | 2025 |
| Abstract P3-03-24: Assessment of cell signaling pathway activity and expression of MKI67, ESR1 and ERBB2 as profiling tool for selection of targeted therapy in breast cancer Y Wesseling-Rozendaal, D van Strijp, E Biezen, A Pierik, R Babkowski Clinical Cancer Research 31 (12_Supplement), P3-03-24-P3-03-24, 2025 | | 2025 |
